PREVNAR 20 9 Drug Interactions

Pneumococcal 20-valent Conjugate Vaccine [Diphtheria CRM197 Protein]

(

If PREVNAR 20 is administered at the same time as another injectable vaccine, the vaccines should always be administered with different syringes and given at different injection sites.

Do not mix PREVNAR 20 with other vaccines/products in the same syringe.

Adults

PREVNAR 20 can be administered concomitantly with influenza vaccine, adjuvanted quadrivalent (QIV) or with COVID-19 mRNA vaccine (see 14 CLINICAL TRIALS, Concomitant vaccine administration)

Infants and Children 6 Weeks To <5 Years of Age

In infants and children 6 weeks to <5 years of age, PREVNAR 20 can be administered concomitantly with any of the following vaccine antigens, either as monovalent or combination vaccines: diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type b, inactivated poliomyelitis, hepatitis B, measles, mumps, rubella (MMR) and varicella vaccines. The vaccine has been safely administered with influenza and rotavirus vaccine.

There are no data on the concomitant administration of PREVNAR 20 with other vaccines.

)

Find PREVNAR 20 medical information:

Find PREVNAR 20 medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PREVNAR 20 Quick Finder

Product Monograph
Download Product Monograph

Health Professional Information

9 Drug Interactions

If PREVNAR 20 is administered at the same time as another injectable vaccine, the vaccines should always be administered with different syringes and given at different injection sites.

Do not mix PREVNAR 20 with other vaccines/products in the same syringe.

Adults

PREVNAR 20 can be administered concomitantly with influenza vaccine, adjuvanted quadrivalent (QIV) or with COVID-19 mRNA vaccine (see 14 CLINICAL TRIALS, Concomitant vaccine administration)

Infants and Children 6 Weeks To <5 Years of Age

In infants and children 6 weeks to <5 years of age, PREVNAR 20 can be administered concomitantly with any of the following vaccine antigens, either as monovalent or combination vaccines: diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type b, inactivated poliomyelitis, hepatitis B, measles, mumps, rubella (MMR) and varicella vaccines. The vaccine has been safely administered with influenza and rotavirus vaccine.

There are no data on the concomitant administration of PREVNAR 20 with other vaccines.

Resources

Didn’t find what you were looking for? 

Contact us

Call 1-800-463-6001*

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: 1 866 723-7111.

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

Canada Vigilance Program 

You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect.